← Back to Search

Diabetes Education for Type 2 Diabetes

N/A

Recruiting

Led By Pearl McElfish, PhD

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with type 2 diabetes (HbA1c equal to or greater than 6.5%)

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediate post-intervention, 4 months post-intervention, 12 months post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether diabetes self-management education and support delivered in faith-based organizations by trained community health workers is effective in improving glycemic control for Marshallese people with type 2 diabetes.

Who is the study for?

This trial is for Marshallese adults with type 2 diabetes who have an HbA1c level of at least 6.5% and a family member to join them in the study. They shouldn't plan to move away, have conditions preventing protocol adherence, severe disabilities, or prior diabetes education within five years.

What is being tested?

The study tests a Family Model Diabetes Self-Management Education program delivered by community health workers in churches. Participants are randomly assigned to start immediately or wait (wait-list control), measuring effects on blood sugar control and other health indicators.

What are the potential side effects?

Since this intervention involves education and support rather than medication, typical drug side effects aren't expected. However, participants may experience stress or discomfort from lifestyle changes or frequent health monitoring required by the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have type 2 diabetes with an HbA1c of 6.5% or higher.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediate post-intervention, 4 months post-intervention, 12 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediate post-intervention, 4 months post-intervention, 12 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediate post-intervention, 4 months post-intervention, 12 months post-intervention for reporting.